Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Best Practice & Research. Clinical Gastroenterology
|
August 21, 2022
Hereditary pancreatic cancer
Derk C F Klatte, Michael B Wallace, Matthias Löhr, et al.
Best Practice & Research. Clinical Gastroenterology
|
April 10, 2025
Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals
Aleksander M Bogdanski, Pilar Acedo, Michael B Wallace, et al.
United European Gastroenterology Journal
|
November 7, 2024
Pancreatic cancer surveillance: Risk stratification of individuals with a germline CDKN2A pathogenic variant
Derk C F Klatte, Jihane Meziani, Djuna L Cahen, et al.
Preventive Medicine Reports
|
February 23, 2023
Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes
Derk C F Klatte, Kristin E Clift, Sarah K Mantia, et al.
Journal of Genetic Counseling
|
October 25, 2023
Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study
Derk C F Klatte, Anke M Onnekink, Chris Hinnen, et al.
Familial Cancer
|
April 15, 2024
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer
Aleksander M Bogdanski, Jeanin E van Hooft, Bas Boekestijn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 4, 2024
Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma
Derk C F Klatte, Alexander Weston, Yaohua Ma, et al.
JCO Oncology Practice
|
April 15, 2024
Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma
Derk C F Klatte, Jason S Starr, Kristin E Clift, et al.
Gastroenterology
|
June 7, 2017
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Derk C F Klatte, Alessandro Gasparini, Hong Xu, et al.
The American Journal of Gastroenterology
|
December 22, 2025
Association Between CT-Based AI-Derived Body Composition and Survival in Patients With Pancreatic Ductal Adenocarcinoma
Koen J H Wijsman, Derk C F Klatte, Hani M Babiker, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Best Practice & Research. Clinical Gastroenterology
|
August 21, 2022
Hereditary pancreatic cancer
Derk C F Klatte, Michael B Wallace, Matthias Löhr, et al.
Best Practice & Research. Clinical Gastroenterology
|
April 10, 2025
Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals
Aleksander M Bogdanski, Pilar Acedo, Michael B Wallace, et al.
United European Gastroenterology Journal
|
November 7, 2024
Pancreatic cancer surveillance: Risk stratification of individuals with a germline CDKN2A pathogenic variant
Derk C F Klatte, Jihane Meziani, Djuna L Cahen, et al.
Preventive Medicine Reports
|
February 23, 2023
Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes
Derk C F Klatte, Kristin E Clift, Sarah K Mantia, et al.
Journal of Genetic Counseling
|
October 25, 2023
Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study
Derk C F Klatte, Anke M Onnekink, Chris Hinnen, et al.
Familial Cancer
|
April 15, 2024
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer
Aleksander M Bogdanski, Jeanin E van Hooft, Bas Boekestijn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 4, 2024
Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma
Derk C F Klatte, Alexander Weston, Yaohua Ma, et al.
JCO Oncology Practice
|
April 15, 2024
Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma
Derk C F Klatte, Jason S Starr, Kristin E Clift, et al.
Gastroenterology
|
June 7, 2017
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Derk C F Klatte, Alessandro Gasparini, Hong Xu, et al.
The American Journal of Gastroenterology
|
December 22, 2025
Association Between CT-Based AI-Derived Body Composition and Survival in Patients With Pancreatic Ductal Adenocarcinoma
Koen J H Wijsman, Derk C F Klatte, Hani M Babiker, et al.
Page
of 2